• Home
  • Intranet
Center for Skeletal Research
  • About Us
  • Cores
  • People
  • Protocols
  • Publications
  • Journal Clubs
  • Funding Opportunities
  • Events
  • News
  • Recordings and Surveys
    • Recordings
      • Recordings for members-only
      • Recordings available to all
    • Surveys
  • Menu Menu
Search

Survey: Interest in Novel CSR Services

Survey: Interest in Novel CSR Services

February 2023/in Uncategorized /by Melissa Machado

Interest in Novel CSR Services

Please select your level of interest in the following services by the Center for Skeletal Research

Name

Translational Imaging and Biomechanics Core

Core overview: Translational Imaging and Biomechanics core is focused on bridging the basic science findings to clinical observations though imaging and biomechanical assessments to assist with studying the disease mechanism, biomarkers, and treatments for a range of skeletal disorders. The core offers a diverse range of services including: 1) Quantitative imaging to assess joint morphology and tissue structural properties 2) Experimental and computational evaluation of tissue mechanical properties 3) Clinical cohort identification (e.g., patients with certain musculoskeletal disorders) to build multi-center database of imaging, clinical and genomics data to help better interpret and validate the preclinical observations
Indicate the likelihood of your using this core in the next 3-4 years

Directed Differentiation Core Services

Core overview: Dr. Craft and her lab are available to discuss investigator-driven projects, experimental design, and provide hands-on training for generating working stocks of human iPSCs/ESCs and mouse PSCs, directed differentiations, deriving appropriate culture conditions and media compositions to support novel protocols, and troubleshooting existing protocols.
Indicate the likelihood of your using this core in the next 3-4 years

Arthritis model systems and analyses

Core overview: aims to address a need to support CSR musculoskeletal researchers to expand their studies from their original research toward the understanding of the mechanism of joint diseases, including osteoarthritis, osteoimmunology and joint structure pathology. The core directors will provide consultative services to CSR members to embark on a pilot project in these specific areas.
Consultative service 1: Advice on osteoarthritis models, including injury-induced animal models and human in vitro models, histological analysis of joint structures and advanced imaging technologies to visualize joint changes.
Indicate the likelihood of your using this service in the next 3-4 years

Consultative service 2: Advice on models of inflammatory arthritis, including rheumatoid arthritis and psoriatic arthritis, as well as histological and osteoimmunological analysis of these models.
Indicate the likelihood of your using this service in the next 3-4 years

Consultative service 3: Advice on models of rheumatoid arthritis, including TNF mouse models, SKG model of RA, and serum transfer arthritis models as well as approaches of microCT, histology, morphology and AAV targeting.
Indicate the likelihood of your using this service in the next 3-4 years

Consultative service 4: Advice on the analysis of the enthesis, including pathophysiology, molecular techniques, histology, mouse models and imaging.
Indicate the likelihood of your using this service in the next 3-4 years

Spatial Transcriptomics

Core overview: Matt Warman

Indicate the likelihood of your using this core in the next 3-4 years

Translational Therapeutics Working Group

Core overview: The Translational Therapeutics Core will serve three main educational functions for the CSR community. First, we will work with CSR leadership to incorporate translational research topics into scientific programming for the annual CSR symposium and monthly Friday afternoon seminars. Second, we will provide ad hoc advice for CSR community members on emerging translational research projects in their laboratories. Given our respective areas of expertise, Jae Shim will provide advice for projects where macromolecules and gene therapy (RNAi, nanoparticle, AAV delivery) interventions are most appropriate, while Marc Wein will provide advice on small molecule, cell therapy, and CRISPR-based gene editing. Finally, if needed, we will help interested investigators identify appropriate institutional resources to assist with issues related to intellectual property and commercialization, and provide high-level advice regarding balancing ‘basic’ and ‘translational’ research activities within academic laboratories.

Indicate the likelihood of your using this core in the next 3-4 years
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail

To Place an Order

Create an Account
Login to Existing Account

Become a Member

The benefits of membership in P30 include subsidized rates in the CSR cores, experienced faculty to assist with projects, networking with other bone scientists, and much more.

Join Today
Twitter Follow us on Twitter.
Tweets by CSR_MGH

News

  • NEW: Directed Differentiation Core ServicesJanuary 2023 - 10:11 am

    PI: April Craft, PhD Assistant Professor of Orthopedic Surgery, BCH, HMS; Affiliate Faculty, Stem Cells & Regenerative Biology; Principal Faculty, Harvard Stem Cell Institute; Co-Director, Musculoskeletal Disease Program, HSCI Email:  april.craft@childrens.harvard.edu      […]

  • NEW CORE: Arthritis and Joint Structure CoreJanuary 2023 - 3:57 pm

    Innovation Award for use of new Arthritis and Joint Structure Core Click Here to access the application. Email filled out applications to CSRmail@partners.org. This award will provide up to $5000 […]

  • CSR Mentee Survey for CSR TraineesNovember 2022 - 12:12 pm
  • Northeastern University Open Rank: Assistant/Associate/Professor – Healthy Aging, Department of BiologyOctober 2022 - 3:31 pm

    Click Here for the application link and the job description

Navigation

  • Home
  • About Us
  • Research Cores
  • People
  • Protocols
  • Funding Opportunities
  • News
  • Events
  • Publications
  • Intranet

Contact us

Center for Skeletal Research
Endocrine Unit
Massachusetts General Hospital
50 Blossom Street, Thier 1101
Boston, MA 02114-2696

Telephone: 617-726-3967
Fax: 617-726-7543
Email: csrmail@partners.org

Visit Us

© 2017 Center for Skeletal Research. Site by Academic Web Pages.
  • Home
  • About Us
  • Research Cores
  • People
  • Protocols
  • Funding Opportunities
  • News
  • Events
  • Publications
  • Intranet
Interest in Novel CSR Services 8th Annual Skeletal Research Symposium Registration
Scroll to top